Beam Therapeutics, Inc. is a biotechnology company, which engages in the establishment of integrated platform for precision genetic medicines. Its pipeline includes BEAM-101, BEAM-302, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-301, and BEAM-201. The company was founded by David R. Liu, Feng Zhang, Alexis Komor, Nicole Gaudelli, and J. Keith Joung on January 25, 2017 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
483
Frequently Asked Questions
What is Market Cap of Beam Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Beam Therapeutics Inc market cap is $2.63B.
What is the 52-week high for Beam Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Beam Therapeutics Inc 52 week high is $35.25 as of October 19, 2025.
What is the 52-week low for Beam Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Beam Therapeutics Inc 52 week low is $13.53 as of October 19, 2025.
What is Beam Therapeutics Inc stock price today?
Beam Therapeutics Inc stock price today is $25.98.
What was Beam Therapeutics Inc stock price yesterday?
Beam Therapeutics Inc stock price yesterday was $25.79.
What is the PE ratio of Beam Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Beam Therapeutics Inc’s P/E ratio is -5.76.
What is the Price-to-Book ratio of Beam Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Beam Therapeutics Inc P/B ratio is 2.5006.
What is the 50-day moving average of Beam Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Beam Therapeutics Inc 50-day moving average is $21.32.
How many employess does Beam Therapeutics Inc has?